This article, written by Assistant Editor Alicia Kort, was excerpted from Newsweek’s Special Edition, Weed 2016: The Beginning of the End for Pot Prohibition. In the 1980s, scientists working for Pfizer set their sights on developing a drug for the pharmaceutical giant that would relieve hypert...

BING NEWS:
  • Why the obesity drug market is about to get a lot more crowded
    The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
    04/26/2024 - 2:15 am | View Link
  • Big Pharma Q1 earnings roundup: AstraZeneca, BMS, Merck, Sanofi
    A group of prominent pharma companies unveiled their respective earnings Thursday morning, with some soaring and others reeling.
    04/25/2024 - 4:56 am | View Link
  • Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
    Bristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now arguably no longer part of the big pharma club. After reporting disappointing earnings figures on ...
    04/25/2024 - 4:15 am | View Link
  • Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
    Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.
    04/25/2024 - 1:35 am | View Link
  • Big pharma seeks innovation in China despite geopolitical turmoil
    Big pharma continues to seek innovation in China despite rising geopolitical tension, speakers said at the Asia Bio Partnering Forum in Singapore April 24.
    04/23/2024 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News